Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: A systematic overview of randomized placebo-controlled trials

American Journal of Kidney Diseases

Volumn 35, Issue 4, 2000, Pages 695-707

  Kshirsagar, Abhijit V ^a   Joy, Melanie S ^a   Hogan, Susan L ^a   Falk, Ronald J ^a   Colindres, Romulo E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin converting enzyme (ACE) inhibitors; Diabetic renal disease; Meta analysis; Nondiabetic renal disease; Randomized clinical trial

Indexed keywords

CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; PLACEBO;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MICROALBUMINURIA; RANDOMIZED CONTROLLED TRIAL; RISK;

EID: 0034113852     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(00)70018-7     Document Type: Article

References (53)

1. L Rosivall G Navar Effects on renal hemodynamics of intra-arterial infusions of angiotensins I and II Am J Physiol 245 1993 F181 F187
2. T Yamada M Horiuchi VJ Dzau Angiotensin II type 2 receptor mediates programmed cell death Proc Natl Acad Sci U S A 93 1996 156 160
3. G Wolf EG Neilson Angiotensin as a renal growth factor J Am Soc Nephrol 3 1993 1531 1540
4. F Lyall JJ Morton AF Lever EJ Cragoe Angiotensin II activates Na-H exchange and stimulates growth in cultured vascular smooth muscle cell J Hypertens 6 suppl 4 1988 S438 S441
5. BF Palmer The renal tubule in the progression of chronic renal failure J Invest Med 45 1997 346 361
6. R Zatz BR Dunn TW Meyer S Anderson HG Rennke BM Brenner Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension J Clin Invest 77 1986 1925 1930
7. S Anderson Antihypertensive therapy in experimental diabetes J Am Soc Nephrol 3 suppl 1 1992 S86 S96
8. N Perico SC Amuchastegui V Colosio G Sonzogni T Bertani G Remuzzi Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which treatment is started J Am Soc Nephrol 5 1994 1139 1146
9. G Maschio D Alberti G Janin F Locatelli JFE Mann M Motolese C Ponticelli E Ritz P Zuchelli the Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 334 1996 939 945
10. GJ Becker JA Whitworth BU Ihle S Shahinfar PS Kincaid-Smith Prevention of progression in non-diabetic chronic renal failure Kidney Int 45 suppl 45 1994 S167 S170
11. BU Ihle JA Whitworth S Shahinfar A Cnaan PS Kincaid-Smith GJ Becker Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: A controlled double-blind trial Am J Kidney Dis 27 1996 489 495
12. The GISEN Group Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy Lancet 349 1997 1857 1862
13. R Bergemann D Wohler P Weidmann J Betzin T Nawrath Verbesserte Glucoseeinstellung und Mikroalbuminurie/Proteinurie bei Diabetikern unter ACE-Hemmer-Behandlung Schweiz Med Wschr 122 1992 1369 1376
14. L Bohlen M de Courten P Weidmann Comparative study of the effect of ACE inhibitors and other antihypertensive agents on proteinuria in diabetic patients Am J Hypertens 7 suppl 7 1994 S84 S92
15. BL Kasiske RSN Kalil JZ Ma M Liao WF Keane Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis Ann Intern Med 118 1993 129 138
16. RT Gansevoort WJ Sluiter MH Hemmelder D de Zeeuw PE de Jong Antiproteinuric effect of blood-pressure lowering agents: A meta-analysis of comparative trials Nephrol Dial Transplant 10 1995 1963 1974
17. DD Maki JZ Ma TA Louis BL Kasiske Long-term effects of antihypertensive agents on proteinuria and renal function Arch Intern Med 155 1995 1073 1080
18. I Giatras J Lau AS Levey Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials Ann Intern Med 127 1997 337 345
19. K Dickerson K Larson Establishing and maintaining an international register of RCTs, in Cochrane Collaboration Handbook, issue no. 3 1995 Cochrane Collaboration Oxford, England
20. M Marre G Chatellier H Leblanc TT Guyene J Menard P Passa Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria BMJ 297 1988 1092 1095
21. M Ravid H Savin I Jutrin T Bental B Katz M Lishner Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients Ann Intern Med 118 1993 577 581
22. HP Chase SK Garg S Harris S Hoops WE Jackson DL Holmes Angiotensin-converting enzyme inhibitor treatment for young normotensive diabetic subjects: A two year trial Ann Ophthalmol 25 1993 284 289
23. G Viberti CE Mogensen LC Groop JF Pauls for the European Microalbuminuria Captopril Study Group Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria JAMA 271 1994 275 279
24. LMB Laffel JB McGill DJ Gans on behalf of the North American Microalbuminuria Study Group The beneficial effects of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria Am J Med 99 1995 497 504
25. The EUCLID Study Group Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria Lancet 349 1997 787 792
26. JH Bauer GP Reams J Hewett D: A Klachko randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy Am J Kidney Dis 20 1992 443 457
27. EJ Lewis LG Hunsicker RP Bain RD Rohde for the Collaborative Study Group The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
28. HE Lebovitz TB Wiegmann A Cnaan S Shahinfar DA Sica V Broadstone SL Schwartz MC Mengel R Segal JA Versaggi WK Bolton Renal protective effects of enalapril in hypertensive NIDDM: Role of baseline albuminuria Kidney Int 45 suppl 45 1994 S150 S155
29. M Capek C Schnack B Ludvik A Kautzky-Willer M Banyai R Prager Effect of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: A long-term study Clin Invest 72 1994 961 966
30. M Stornello EV Valvo L Scapellato Angiotensin-converting enzyme inhibition in normotensive type II diabetic patients with persistent mild proteinuria J Hypertens 7 suppl 6 1989 S314 S315
31. GL Bakris R Slataper N Vicknair R Sadler ACE inhibitor-mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects J Diabetes Complications 8 1994 2 6
32. J Ahmad MA Siddiqui H Ahmad Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria Diabetes Care 20 1997 1576 1582
33. G Crepaldi Q Carta G Deferrari R Mangili R Navalesi F Santeusanio A Spalluto A Vanasia GM Villa The Italian Microalbuminuria Study Group Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure Diabetes Care 21 1998 104 110
34. EB Pedersen JN Bech CB Nielsen NH Kornerup HE Hansen ES Spencer J Solling KT Jensen A comparison of the effect of ramipril, felodipine, and placebo on glomerular filtration rate, albuminuria, blood pressure and vasoactive hormones in chronic glomerulonephritis Scand J Clin Lab Invest 57 1997 673 681
35. A Nankervis K Nicholls G Kilmartin P Allen S Ratnaike FIR Martin Effect of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria: A 3-year placebo-controlled biopsy study Metabolism 47 suppl 1 1998 S12 S15
36. JJ Gart JR Zweifel On the bias of various estimators of logit and its variance with application of quantal bioassay Biometrika 54 1967 181 195
37. JL Fleiss The statistical basis of meta-analysis Stat Methods Med Res 2 1993 121 145
38. R DerSimonian N Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 186
39. P Jungers P Chauveau B Seschamps-Latscha Age and gender-related incidence of chronic renal failure in a French urban area: A prospective epidemiologic study Nephrol Dial Transplant 11 1996 1542 1546
40. US Renal Data System USRDS 1997 Annual Data Report 1997 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 149
41. CP Gross GF Anderson NR Powe The relationship between funding by the National Institutes of Health and the burden of disease N Engl J Med 340 1999 1881 1887
42. TV Perneger FL Brancati PK Whelton MJ Klag Studying the causes of kidney disease in humans: A review of methodologic obstacles and possible solution Am J Kidney Dis 25 1995 722 731
43. The SOLVD Investigators Effects of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 327 1992 685 691
44. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1987 1429 1435
45. MA Pfeffer E Braunwald LA Moye L Basta EJ Brown TE Cuddy BR Davis EM Geltman S Goldman GC Flaker M Klein GA Lamas M Packer J Rouleau JL Rouleau J Rutherford JH Wertheimer CM Hawkins on behalf of the SAVE Investigators Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial N Engl J Med 327 1992 669 677
46. F Locatelli IRI Carbarns G Maschio JFE Mann C Ponticelli E Ritz D Alberti M Motolese G Janin P Zucchelli and the Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. Long-term progression of chronic renal insufficiency in the AIPRI extension study Kidney Int 52 suppl 63 1997 S63 S66
47. CE Mogensen Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy BMJ 285 1982 685 689
48. HH Parving AR Andersen UM Smidt PA Svendsen Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy Lancet I 1983 1175 1179
49. S Klahr AS Levey GJ Beck AW Caggiula L Hunsicker JW Kusek G Striker for the Modification of Diet in Renal Disease Study Group The effects of dietary proteinrestriction and blood-pressure control on the progression of chronic renal disease N Engl J Med 330 1994 877 884
50. The Diabetes Control and Complications Trial Research Group The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus N Engl J Med 329 1993 977 986
51. LM Friedman CD Furberg DL DeMets Fundamentals of Clinical Trials ed 3 1996 MO, Mosby-Year-Book St Louis 43 46
52. CH Hennekens JE Buring Epidemiology in Medicine ed 1 1987 Little, Brown Boston, MA 187 189
53. US Renal Data System USRDS 1994 Annual Data Report 1994 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 43 54